Media Coverage Archives - Page 28 of 30 - Lupin

BSE 2296.10 NSE 2296.10

indian flag icon

India

USA

great-britain flag icon

UK

south-africa flag icon

South Africa

australia flag icon

Australia

philippines flag icon

Philippines

germany flag icon

Germany

netherlands flag icon

Netherlands

mexico flag icon

Mexico

brazil flag icon

Brazil

canada flag icon

Canada

Switzerland flag icon

Switzerland

BSE 2296.10 NSE 2296.10

Price relief for diabetes patients as drugs go off patent – Rajeev Sibal

January 5, 2020

Lupin has gained significant momentum towards development of biosimilar products with primary focus on regulated markets – Dr Cyrus Karkaria

December 4, 2019

The toughest period is behind us, says Lupin’s Vinita Gupta

November 30, 2019

Lupin’s Karkaria On Biosimilars Pushback And Interchangeability

November 25, 2019

Lupin to expand Ghotawade plant to target Europe, US

November 12, 2019

Pharma’s new world dares Lupin’s Vinita Gupta once again. And she is set to fight it out

November 8, 2019

Lupin targets Europe and US biosimilars market – Dr Cyrus Karkaria

October 22, 2019

Lupin plans to file pegfilgrastim biosimilar drug in Q4FY20 in US – Dr Cyrus Karkaria

October 14, 2019

Lupin plans to file Etanercept, Pegfilgrastim biosimilars in US by Q4FY20 – Dr Cyrus Karkaria

October 11, 2019

Interaction with Dr. Karkaria on Biosimilars

October 11, 2019

1 2 … 27 28 29 30

Search

Hit enter to search or ESC to close